Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2021

Same author

Impact of COVID-19 outbreak on emergency surgery and emergency department admissions: an Italian level 2 emergency department experience.

The British journal of surgery·2020

Same author

Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity.

The British journal of surgery·2019

Same author

Corrigendum to "Intensive lifestyle modifications with or without liraglutide 3mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study" [Diabetes Metab. 44 (2018) 235-242].

Diabetes & metabolism·2019

Same author

Intensive lifestyle modifications with or without liraglutide 3mg vs. sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study.

Diabetes & metabolism·2018

Same author

Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery.

Current atherosclerosis reports·2017

Search research articles

Related Experiment Video

Updated: May 21, 2026

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Insulin sensitivity and secretion modifications after bariatric surgery.

L Castagneto-Gissey¹, G Mingrone

¹Department of Internal Medicine, Catholic University of Rome, Rome, Italy.

Journal of Endocrinological Investigation

|June 27, 2012

Summary

Bariatric surgery significantly improves Type 2 diabetes in obese patients, with malabsorptive procedures showing the most durable glucose control. Different surgical techniques impact insulin sensitivity and secretion uniquely.

More Related Videos

Roux-en-Y Gastric Bypass Operation in Rats

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Roux-en-Y Gastric Bypass Operation in Rats

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Area of Science:

Metabolic Surgery
Endocrinology
Obesity Medicine

Background:

Rising prevalence of Type 2 diabetes mellitus (T2DM) linked to obesity epidemics.
T2DM accounts for a significant portion of healthcare costs in Europe.
Obesity significantly impacts glucose metabolism and insulin resistance.

Purpose of the Study:

To analyze the effectiveness of bariatric surgery in managing T2DM.
To compare the impact of different bariatric procedures on glucose control, insulin sensitivity, and secretion.
To elucidate the mechanisms by which bariatric surgery improves T2DM outcomes.

Main Methods:

Meta-analysis of existing literature on bariatric surgery and T2DM.
Review of studies examining clinical and laboratory manifestations of T2DM post-surgery.
Comparative analysis of various bariatric surgical techniques (Roux-en-Y Gastric Bypass, Biliopancreatic Diversion, Gastric Banding, Sleeve Gastrectomy).

Main Results:

Bariatric surgery resolved T2DM in 78.1% and improved it in 86.6% of obese patients (BMI >35 kg/m²).
Malabsorptive procedures demonstrated the most significant and durable improvements in glucose control.
Roux-en-Y Gastric Bypass enhances post-meal insulin secretion, while Biliopancreatic Diversion improves insulin sensitivity.

Conclusions:

Bariatric surgery is highly effective for T2DM remission and improvement in obese individuals.
The choice of bariatric procedure influences the degree and durability of glycemic control.
Understanding the distinct mechanisms of each surgical technique is crucial for optimizing T2DM management.